+86-156-2511-0166[email protected]WhatsApp
Hanheng Refractory
HOMEABOUT
PRODUCTS
All products
APPLICATIONS & INDUSTRIESMARKET SUPPORTNEWS
DISCUSS
Hanheng Refractory
HOMEABOUTAPPLICATIONS & INDUSTRIESMARKET SUPPORTNEWS
DISCUSS
+86-156-2511-0166WhatsApp[email protected]
Hanheng RefractoryHanheng RefractoryBuilt for heat. Proven in delivery.

Hanheng Refractory Materials Co., Ltd. supplies shaped bricks, monolithic refractories, tundish materials, and insulation products for steel, ferroalloy, glass, boiler, and other heat-intensive operations.

Quick links

  • Home
  • About
  • Products
  • Applications & Industries
  • Market Support
  • News

Core products

  • Magnesia-Carbon Brick
  • Alumina-Magnesia-Carbon Brick
  • Magnesia-Alumina-Carbon Brick
  • Al2O3-SiC-C Brick
  • Calcium-Magnesium-Carbon Brick

Contact

Panpan Road, Zhanqian District, Yingkou, Liaoning, Chinawww.hanhengref.com[email protected]+86-156-2511-0166WhatsApp

© 2026 Hanheng Refractory

Project discussionProduct systemPrivacy Policy
Industry update
Published June 4, 2026businesseconomyindustry

CardinalStone completes N21bn Fidson Rights Issue

CardinalStone Partners Limited is proud to announce the successful completion of the N21bn Rights Issue of Fidson Healthcare Plc, Nigeria’s foremost indigenous pharmaceutical manufacturer

Source-backed market reading focused on the local industrial developments, project signals, and operating consequences that are actually worth tracking.

Read Article
Previous article

CardinalStone Partners Limited is proud to announce the successful completion of the N21bn Rights Issue of Fidson Healthcare Plc, Nigeria’s foremost indigenous pharmaceutical manufacturer. The transaction closed at an impressive 117 per cent subscription rate, making it one of the most strongly supported equity capital markets transactions on the Nigerian Exchange Group in recent years.

Acting as Financial Adviser and Issuing House, CardinalStone led the transaction from structuring and regulatory engagement through investor marketing, execution, and final allotment. The successful completion of the Rights Issue reflects the firm’s strong execution capabilities, deep understanding of the Nigerian capital markets, and continued ability to connect credible businesses with long-term domestic capital.

Despite prevailing macroeconomic and liquidity challenges, the 117 per cent oversubscription highlights strong investor confidence in Fidson’s growth strategy and the long-term potential of Nigeria’s healthcare and manufacturing sectors. The strong participation also signals sustained appetite for credible issuers and well-structured investment opportunities within the Nigerian capital markets.

Beyond the immediate success of the capital raise, the transaction represents a significant milestone for Nigeria’s pharmaceutical industry and the broader national economy. At a time when countries around the world are prioritising healthcare security and local manufacturing resilience, the successful funding of an indigenous pharmaceutical leader carries major strategic importance for Nigeria’s future.

Nigeria continues to rely heavily on imported pharmaceutical products and active ingredients, creating significant pressure on foreign exchange demand while exposing the healthcare system to global supply chain disruptions and international market volatility. Expanding local pharmaceutical manufacturing capacity is therefore not only a healthcare priority but also an economic necessity.

The proceeds from the Rights Issue will support Fidson’s expansion across manufacturing infrastructure, product development, and distribution capacity. This investment is expected to deepen local production capabilities, improve access to affordable and quality medicines, strengthen the domestic healthcare value chain, and create more skilled employment opportunities across the sector.

Related News SMEs need infrastructure beyond financing – Senior VP, FCMB Group seeks decentralisation of solid minerals sector Sundry Markets expands to over 40 stores nationwide Importantly, the transaction also contributes to Nigeria’s broader industrialisation agenda by supporting local production, reducing import dependence, conserving foreign exchange, and encouraging the development of globally competitive Nigerian manufacturing businesses.

The multiplier effect extends beyond healthcare into logistics, packaging, research, distribution, retail, and employment generation across the wider economy. As Africa’s largest economy continues to pursue economic diversification and sustainable growth, transactions such as this demonstrate the critical role of the capital markets in mobilising private sector funding toward sectors that directly impact national development and citizen wellbeing.

For CardinalStone, the successful execution of the Fidson Rights Issue further reinforces the firm’s position as one of West Africa’s leading independent investment banking franchises. The transaction adds to the firm’s growing track record of landmark capital market mandates across critical sectors of the economy, reflecting its commitment to delivering innovative financial solutions that drive long-term growth and economic transformation.

This transaction represents far more than a successful capital raise; it underscores the growing role of Nigeria’s capital markets in advancing strategic sectors critical to national development. By supporting the expansion of indigenous pharmaceutical manufacturing, the Fidson Rights Issue contributes meaningfully to strengthening healthcare resilience, deepening local industrial capacity, conserving foreign exchange, creating sustainable employment, and positioning Nigeria for a more self-reliant and globally competitive future.

Next article

Sources and reading line

Public reports, policy documents, and industry releases cited in this article remain available here for continued review.

View cited sources1 sources

CardinalStone completes N21bn Fidson Rights Issue

Published source

Document: Punch Nigeria Business RSS · Source: Punch Nigeria Business RSS

Open source↗
Continue from here

Continue this article into market review, product systems, and project preparation.

When this signal is already affecting your buying sequence, continue from here into the related market page, product route, or a practical project discussion.

Related market pages

Continue into the country page when destination documents, packing, and delivery timing need a deeper read.

Nigeria industry and refractory demandOpen market page
Project preparation

Share the unit, duty position, target campaign, destination market, and document questions so the next reply can stay practical.

Unit name, exact hot-zone position, and current lining route

Target campaign, shutdown or commissioning window, and expected quantity split

Destination market, delivery route, and the document set needed before quotation

Discuss this articleBack to News